Cellular cytotoxicity is a form of immunogenic cell death
BackgroundThe immune response to cancer is often conceptualized with the cancer immunity cycle. An essential step in this interpretation is that antigens released by dying tumors are presented by dendritic cells to naive or memory T cells in the tumor-draining lymph nodes. Whether tumor cell death r...
Main Authors: | Pedro Berraondo, Alvaro Teijeira, Saray Garasa, Iñaki Etxeberrria, Luna Minute, Maria C Ochoa, Maite Alvarez, Itziar Otano, Noelia Casares, Jose Luis Perez Gracia |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-06-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/8/1/e000325.full |
Similar Items
-
755 CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity
by: Alvaro Teijeira, et al.
Published: (2020-11-01) -
Cellular immunotherapies for cancer
by: Pedro Berraondo, et al.
Published: (2017-05-01) -
Enhancement of antibody-dependent cellular cytotoxicity of cetuximab by a chimeric protein encompassing interleukin-15
by: Maria Carmen Ochoa, et al.
Published: (2018-02-01) -
Impact of prophylactic TNF blockade in the dual PD-1 and CTLA-4 immunotherapy efficacy and toxicity
by: Maite Alvarez, et al.
Published: (2019-06-01) -
Correction: Cellular cytotoxicity is a form of immunogenic cell death
by: Ignacio I Wistuba, et al.
Published: (2020-06-01)